Hypoxia-responsive CEA CAR-T cells therapy for relapsed or refractory non-small cell lung cancer: A single-arm, open-label, phase I trial.

C-13-60 - Chongqing Precision Biotech

Shuang Wei; Jiaqi Guo; Xueli Bai; Cheng Qian; Yicheng Zhang; Ling Zhou; Weiwei Tian; Xiansheng Liu; Jia Wei

Apr 23, 2025